Hospital at Smolensk Station

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

Andrey A. Ivashchenko, Kirill Dmitriev, Natalia Vostokova et al. · Clinical Infectious Diseases · 2020 · 258 citations · Full text

May 2020, Russian Ministry, Viral Diagnostics +12

Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study

Evgeniy Nasonov, Saeed Fatenejad, Eugen Feist et al. · Annals of the Rheumatic Diseases · 2021 · 67 citations · Full text

Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”

Mikhail V. Edelstein, N. Ivanchik, E.Yu. Skleenova et al. · Clinical Microbiology and Antimicrobial Chemotherapy · 2019 · 61 citations · Full text

THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY)

E L Nasonov, L. A. Knyazeva, Mazurov Vi et al. · Rheumatology Science and Practice · 2016 · 31 citations · Full text

Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Pseudomonas aeruginosa isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”

Mikhail V. Edelstein, E.Yu. Skleenova, E.R. Shajdullina et al. · Clinical Microbiology and Antimicrobial Chemotherapy · 2019 · 23 citations · Full text